Literature DB >> 9447494

The Overt Agitation Severity Scale for the objective rating of agitation.

S C Yudofsky1, H J Kopecky, M Kunik, J M Silver, J Endicott.   

Abstract

Two studies tested the reliability and validity of the Overt Agitation Severity Scale (OASS), a new instrument developed to define and objectively rate the severity of agitated behavior. The authors postulate that agitation should be conceptualized as vocal and motor behaviors on a continuum of expressions that extends from anxiety to aggression. Content validity through expert agreement was achieved in the development of test construction over a 2-year period. Results of two pilot studies (n = 25 and n = 14 subjects) established the reliability and validity of the OASS to measure agitation severity. The OASS differs from other agitation scales in that it confines its rating exclusively to observable behavioral manifestations of agitation.

Entities:  

Mesh:

Year:  1997        PMID: 9447494     DOI: 10.1176/jnp.9.4.541

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  13 in total

Review 1.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients.

Authors:  H J Kopecky; C R Kopecky; S C Yudofsky
Journal:  Psychiatr Q       Date:  1998

Review 3.  Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Melanie J Brooke-Powney; Xue Li; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 4.  Haloperidol plus promethazine for psychosis-induced aggression.

Authors:  Gisele Huf; Jacob Alexander; Pinky Gandhi; Michael H Allen
Journal:  Cochrane Database Syst Rev       Date:  2016-11-25

5.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 6.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

7.  A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.

Authors:  Kevin Chen; Daniel P Holschneider; Weihua Wu; Igor Rebrin; Jean C Shih
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

Review 8.  Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review.

Authors:  Xin Yu; Christoph U Correll; Yu-Tao Xiang; Yifeng Xu; Jizhong Huang; Fude Yang; Gang Wang; Tianmei Si; John M Kane; Prakash Masand
Journal:  Shanghai Arch Psychiatry       Date:  2016-10-25

9.  Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia.

Authors:  Jenna Roberts; Alfredo Gracia Canales; Sophee Blanthorn-Hazell; Anca Craciun Boldeanu; Davneet Judge
Journal:  BMC Psychiatry       Date:  2018-04-16       Impact factor: 3.630

10.  Anticonvulsants in the treatment of aggression in the demented elderly: an update.

Authors:  Benedikt Amann; Johannes Pantel; Heinz Grunze; Eduard Vieta; Francesc Colom; Ana Gonzalez-Pinto; Dieter Naber; Harald Hampel
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.